SBIROpen

SWiFT: Smart Whole Blood Field Transfusion system

Solicitation ID26.BZ
Agency
DOD
DARPA
Deadline
Jun 3, 2026
23 days left
Posted Date
Apr 13, 2026
Classification
SBIR
Phase: BOTH

SBIR Opportunity Analysis

DARPA, within the Department of Defense, is seeking SBIR proposals for the SWiFT program, a self-contained autonomous device intended to automate blood collection, diagnostic testing, storage, and transfusion for military and civilian use. The effort calls for an integrated system that combines miniaturized technologies, sensors, AI-driven decision logic, and continuous donor and recipient monitoring with automatic alerts, while Phase I focuses on feasibility and conceptual design and Phase II on prototype development and validation. The device is expected to handle end-to-end automation, be ruggedized for austere environments, work across a range of patient sizes and ages, and target a market price below $300 and an empty weight under 5 pounds. Solicitation 26.BZ is open, and applications are due June 3, 2026 at 4:00 PM UTC through the DoD SBIR/STTR topics portal.

SBIR Documents

1 Files
1776211344085.pdf
PDF101 KBMay 11, 2026
AI Summary
The DPA26BZ01-DV003: SWiFT program seeks innovative proposals for a self-contained, autonomous device to revolutionize blood collection and transfusion in military and civilian settings. This device aims to automate the entire process, including blood collection, temporary storage, diagnostic testing, and transfusion, with continuous donor/recipient monitoring and alerts. The current manual process is complex, labor-intensive, and prone to error, leading to low success rates and significant time expenditure in critical situations. The SWiFT system will integrate existing miniaturized technologies, robust sensors, and AI-driven decision logic, ensuring continuous monitoring of vital signs and automatic alerts for adverse events. The objective is to reduce human intervention, errors, and variability while increasing efficiency and safety. Phase I focuses on feasibility, conceptual design, and risk mitigation, including technology down-selection and system architecture. Phase II involves prototype development and validation, aiming for a ruggedized alpha prototype capable of end-to-end transfusion in a laboratory setting. The device is intended for dual-use applications in emergency medical services, hospitals, blood banks, and tactical combat casualty care, with a target market price under $300 and a weight under 5 lbs.

Related SBIR/STTR Opportunities

Opportunity Snapshot

Source SystemOfficial Link
Program Type
SBIR - BOTH
Agency
DOD / DARPA

Key Dates

Release DateApr 13, 2026
Open DateMay 6, 2026
Application DueJun 3, 2026
Close DateJun 3, 2026